MALAT1 and abdominal aortic aneurysm: In addition, relevant experiments accurately identified the MALAT1 inhibitor, a therapeutic agent targeting lncRNA-MALAT, and for the first time, the rationale for the application of this inhibitor in the prevention and treatment of abdominal aortic aneurysms was discovered [59].